We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$652M
AUM Growth
+$21.4M
Cap. Flow
-$20M
Cap. Flow %
-3.06%
Top 10 Hldgs %
31.53%
Holding
180
New
11
Increased
35
Reduced
93
Closed
6

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.69M
2
TMP icon
Tompkins Financial
TMP
+$3.57M
3
NTES icon
NetEase
NTES
+$1.96M
4
AMT icon
American Tower
AMT
+$1.8M
5
INST
Instructure Holdings, Inc.
INST
+$1.65M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$7.15M
2
EMR icon
Emerson Electric
EMR
+$6.15M
3
EQNR icon
Equinor
EQNR
+$4.39M
4
NRG icon
NRG Energy
NRG
+$2.72M
5
ES icon
Eversource Energy
ES
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 31.68%
2 Healthcare 17.44%
3 Industrials 15.98%
4 Utilities 9.18%
5 Energy 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCK icon
76
Crown Holdings
CCK
$13.1B
$2.24M 0.34%
28,289
-300
-1% -$24.6K
PBW icon
77
Invesco WilderHill Clean Energy ETF
PBW
$429M
$2.02M 0.31%
87,700
+24,550
+39% +$590K
NTES icon
78
NetEase
NTES
$84.7B
$1.98M 0.3%
+19,150
New +$1.96M
ALB icon
79
Albemarle
ALB
$15.5B
$1.97M 0.3%
14,925
+6,850
+85% +$843K
SO icon
80
Southern Company
SO
$107B
$1.85M 0.28%
25,800
+100
+0.4% +$6.9K
UTHR icon
81
United Therapeutics
UTHR
$23.1B
$1.78M 0.27%
7,750
-1,380
-15% -$311K
ASTE icon
82
Astec Industries
ASTE
$1.02B
$1.75M 0.27%
40,102
-1,048
-3% -$39.1K
ES icon
83
Eversource Energy
ES
$27.2B
$1.74M 0.27%
29,175
-44,367
-60% -$2.55M
NEE icon
84
NextEra Energy
NEE
$177B
$1.7M 0.26%
26,647
+12,150
+84% +$712K
SNOW icon
85
Snowflake
SNOW
$115B
$1.69M 0.26%
10,432
-300
-3% -$58.2K
BCV
86
Bancroft Fund
BCV
$139M
$1.62M 0.25%
101,122
+8,350
+9% +$130K
WBS icon
87
Webster Financial
WBS
$12.8B
$1.6M 0.25%
31,500
-350
-1% -$17.1K
ACVA icon
88
ACV Auctions
ACVA
$1.3B
$1.24M 0.19%
66,284
– –
DAN icon
89
Dana Inc
DAN
$3.06B
$1.22M 0.19%
96,312
-64,938
-40% -$842K
MRNA icon
90
Moderna
MRNA
$23.6B
$1.21M 0.19%
11,400
+7,750
+212% +$781K
VWO icon
91
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.18M 0.18%
28,269
+1,950
+7% +$79.6K
APTV icon
92
Aptiv
APTV
$10.3B
$1.1M 0.17%
13,850
-21,650
-61% -$1.75M
KMI icon
93
Kinder Morgan
KMI
$68.7B
$1.08M 0.17%
59,120
-2,000
-3% -$34.9K
CVX icon
94
Chevron
CVX
$366B
$1.04M 0.16%
6,601
– –
VIAV icon
95
Viavi Solutions
VIAV
$9.66B
$879K 0.13%
96,650
-5,700
-6% -$55.9K
ELUT icon
96
Elutia
ELUT
$37.6M
$865K 0.13%
29,700
– –
CFFI icon
97
C&F Financial
CFFI
$286M
$860K 0.13%
17,560
+900
+5% +$49.5K
RBB icon
98
RBB Bancorp
RBB
$455M
$856K 0.13%
47,550
-1,000
-2% -$17.7K
BP icon
99
BP
BP
$107B
$836K 0.13%
22,200
– –
CIEN icon
100
Ciena
CIEN
$58.4B
$816K 0.13%
16,500
+1,900
+13% +$100K
2 3
4
5 6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
PWA
Peterson Wealth Advisors Orem, Utah $752M AUM 13.99% 1-Year Est. Return

John G. Ullman & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, John G. Ullman & Associates held 180 positions worth $652M, up 3.4% from $630M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $20M in Q1 2024, closing 6 positions and reducing 93 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Jazz Pharmaceuticals worth $3.63M.

  • John G. Ullman & Associates's largest Q1 2024 buy was Jazz Pharmaceuticals: 30,150 shares worth $3.63M.
  • John G. Ullman & Associates added most to Tompkins Financial in Q1 2024, an estimated $3.57M increase.
  • John G. Ullman & Associates's biggest Q1 2024 reduction was Emerson Electric, cutting an estimated $6.15M.
  • John G. Ullman & Associates fully exited JPMorgan Chase in Q1 2024, selling an estimated $7.15M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $652M portfolio in Q1 2024.
  • John G. Ullman & Associates opened 11 new positions and closed 6 in Q1 2024.
  • John G. Ullman & Associates's portfolio value rose 3.4% quarter-over-quarter to $652M.

Based on John G. Ullman & Associates's 13F filing for Q1 2024, filed 6 May 2024.